Patient enrollment has begun in the confirmatory Phase III clinical trial of BromSite (ISV-303) for the reduction of inflammation and pain following cataract surgery.More »
Phase II and III clinical data show that OMS302, which is being developed by Omeros Corporation, has a favorable impact on reducing the incidence of miosis during intraocular lens (IOL) replacement.More »
Carl Zeiss Meditec announced the ZEISS Cataract Suite, which recently received U.S. FDA 510(k) clearance and assists cataract surgeons in the precise alignment of IOLs.More »
The FDA has approved Abbott's TECNIS Toric 1-Piece intraocular lens (IOL) and the company is launching it in the United States for the treatment of cataract patients with pre-existing corneal astigmatMore »
Bausch + Lomb and Technolas Perfect Vision announced that the Victus Femtosecond Laser Platform received 510(k) clearance from the Food and Drug Administration.More »
FAIRFAX, Va.—The American Society of Cataract and Refractive Surgery (ASCRS) has formed an Integrated Ophthalmic-Managed Eyecare Delivery Task Force to investigate and recommend ways in which the orgaMore »
FAIRFAX, Va.—The Contact Lens Association of Ophthalmologists, a non-profit organization with about 300 members dedicated to providing ophthalmologists, optometrists, and other eye care professionalsMore »
CHICAGO— Prevent Blindness America (PBA) has declared June as Cataract Awareness Month and will provide free information to the public on everything from cataract basics to tips on what to expect fromMore »
